Search

Displaying results 6741 - 6750 of 10000 in total
  1. Drug

    Bizalimogene ralaplasmid

    go.drugbank.com/drugs/DB16113
    Investigational

    Bizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related … Anal or Anal/peri-anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2).

  2. Drug

    Androstenediol

    go.drugbank.com/drugs/DB01524
    ExperimentalIllicit

    Androstenediol is an intermediate in [testosterone] biosynthesis, found in the testis or the adrenal glands. … Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a

    Synonyms: androst-5-ene-3beta,17beta-diol
  3. Drug

    XC221

    go.drugbank.com/drugs/DB16503
    Investigational

    XC221 was investigated in clinical trials to treat patients with respiratory infections, including influenza, COVID-19, and other acute viral upper respiratory infections.

  4. Drug

    Recombinant Human Thrombopoietin

    go.drugbank.com/drugs/DB16364
    Investigational

    [A225691, A225696] This drug is used in the treatment of thrombocytopenia. … Recombinant human thrombopoietin is a full-length glycosylated cytokine produced by Chinese hamster ovary cells and is used to promote the generation of megakaryocytes and platelets.

  5. Drug

    NasoVAX

    go.drugbank.com/drugs/DB15859
    Investigational

    NasoVAX contains replication-deficient adenovirus vectors in suspension. It is a vaccine administered through a nasal spray that expresses influenza hemagglutinin in nasal epithelial cells[L16313]. … As of June 2020, NasoVAX is being evaluated in a Phase 2 clinical trial for safety and effectivness in preventing worsening symptoms in hospitalized COVID-19 patients (NCT04442230).

  6. Drug

    Tizaterkib

    go.drugbank.com/drugs/DB21296
    Investigational

    Tizaterkib is a small molecule drug. The usage of the INN stem '-terkib' in the name indicates that Tizaterkib is a extracellular signal-regulated kinase (ERK) inhibitor. … Tizaterkib has a monoisotopic molecular weight of 494.2 Da.

  7. Drug

    Ludaterone

    go.drugbank.com/drugs/DB21476
    Experimental

    Ludaterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Ludaterone is a antiandrogen. Ludaterone has a monoisotopic molecular weight of 380.14 Da.

  8. Drug

    Teslexivir

    go.drugbank.com/drugs/DB21202
    Experimental

    Teslexivir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Teslexivir is a antiviral. Teslexivir has a monoisotopic molecular weight of 641.19 Da.

  9. Drug

    Flosatidil

    go.drugbank.com/drugs/DB19611
    Experimental

    Flosatidil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Flosatidil is a vasodilator. Flosatidil has a monoisotopic molecular weight of 525.23 Da.

  10. Drug

    Resorantel

    go.drugbank.com/drugs/DB19728
    Experimental

    Resorantel is a small molecule drug. The usage of the INN stem '-antel' in the name indicates that Resorantel is a anthelminthic. Resorantel has a monoisotopic molecular weight of 306.98 Da.